Compare KALA & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALA | MKZR |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.9M |
| IPO Year | 2017 | 2012 |
| Metric | KALA | MKZR |
|---|---|---|
| Price | $3.04 | $1.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 164.5K | 10.4K |
| Earning Date | 12-01-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.39 | 48.87 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,007,414.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.83 |
| 52 Week High | $191.00 | $5.22 |
| Indicator | KALA | MKZR |
|---|---|---|
| Relative Strength Index (RSI) | 77.25 | 49.55 |
| Support Level | $2.07 | $1.01 |
| Resistance Level | $3.71 | $1.23 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | 0.38 | 0.02 |
| Stochastic Oscillator | 73.26 | 60.89 |
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Mackenzie Realty Capital Inc is a real estate investment manager and a real estate investment trust (REIT) engaged in discounted real estate securities and asset management. The Company operates through two primary operating and reportable segments: commercial, which generates maximum revenue, and residential. These segments include activities related to acquiring, owning, developing, and managing income-producing real estate properties. Its properties are geographically diversified throughout the United States.